| Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis H Appel, G Ruiz‐Heiland, J Listing, J Zwerina, M Herrmann, R Mueller, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 389 | 2009 |
| Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort A Ciurea, A Scherer, P Exer, J Bernhard, J Dudler, B Beyeler, R Kissling, ... Arthritis & Rheumatism 65 (12), 3096-3106, 2013 | 192 | 2013 |
| Treatment with biologicals in rheumatoid arthritis: an overview P Rein, RB Mueller Rheumatology and therapy 4 (2), 247-261, 2017 | 181 | 2017 |
| Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study M Cutolo, AL Herrick, O Distler, MO Becker, E Beltran, P Carpentier, ... Arthritis & rheumatology 68 (10), 2527-2539, 2016 | 162 | 2016 |
| Impaired hand size estimation in CRPS E Peltz, F Seifert, S Lanz, R Müller, C Maihöfner The journal of pain 12 (10), 1095-1101, 2011 | 132 | 2011 |
| Induction of osteoclast‐associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis S Herman, RB Müller, G Krönke, J Zwerina, K Redlich, AJ Hueber, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 115 | 2008 |
| Efficacy and safety of belimumab and azathioprine for maintenance of remission in antineutrophil cytoplasmic antibody–associated vasculitis: a randomized controlled study D Jayne, D Blockmans, R Luqmani, S Moiseev, B Ji, Y Green, L Hall, ... Arthritis & Rheumatology 71 (6), 952-963, 2019 | 102 | 2019 |
| The role of annexin A5 in the modulation of the immune response against dying and dead cells LE Munoz, B Frey, F Pausch, W Baum, RB Mueller, B Brachvogel, ... Current medicinal chemistry 14 (3), 271-277, 2007 | 98 | 2007 |
| How to get the most from methotrexate (MTX) treatment for your rheumatoid arthritis patient?—MTX in the treat-to-target strategy PC Taylor, A Balsa Criado, AB Mongey, J Avouac, H Marotte, RB Mueller Journal of clinical medicine 8 (4), 515, 2019 | 72 | 2019 |
| Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis A Ciurea, A Scherer, U Weber, P Exer, J Bernhard, G Tamborrini, M Riek, ... Annals of the rheumatic diseases 75 (3), 532-539, 2016 | 70 | 2016 |
| Attraction of phagocytes by apoptotic cells is mediated by lysophosphatidylcholine RB Mueller, A Sheriff, US Gaipl, S Wesselborg, K Lauber Autoimmunity 40 (4), 342-344, 2007 | 69 | 2007 |
| CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis B Vogt, B Führnrohr, R Müller, A Sheriff Autoimmunity 40 (4), 295-298, 2007 | 69 | 2007 |
| Functional and Structural Defects in HIV Type 1 nef Genes Derived from Pediatric Long-Term Survivors R Geffin, D Wolf, R Müller, MD Hill, E Stellwag, M Freitag, G Sass, ... AIDS research and human retroviruses 16 (17), 1855-1868, 2000 | 67 | 2000 |
| Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort RB Mueller, T Kaegi, A Finckh, SR Haile, H Schulze-Koops, J von Kempis Rheumatology 53 (4), 671-677, 2014 | 66 | 2014 |
| Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-α-elicited endothelial activation G Di Comite, CM Rossi, A Marinosci, K Lolmede, E Baldissera, P Aiello, ... Journal of Leucocyte Biology 85 (1), 81-87, 2009 | 62 | 2009 |
| Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double … MH Schiff, J Von Kempis, R Goldblum, JR Tesser, RB Mueller Annals of the rheumatic diseases 73 (12), 2174-2177, 2014 | 58 | 2014 |
| Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: a retrospective analysis of real-world data from the St. Gallen cohort RB Müller, J von Kempis, SR Haile, MH Schiff Seminars in arthritis and rheumatism 45 (1), 28-34, 2015 | 56 | 2015 |
| Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with … A Finckh, C Tellenbach, L Herzog, A Scherer, B Moeller, A Ciurea, ... RMD open 6 (1), e001174, 2020 | 53 | 2020 |
| Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis D Alpizar-Rodriguez, RB Mueller, B Möller, J Dudler, A Ciurea, P Zufferey, ... Rheumatology 56 (9), 1579-1585, 2017 | 49 | 2017 |
| Effectiveness, tolerability, and safety of tofacitinib in rheumatoid arthritis: a retrospective analysis of real-world data from the St. Gallen and Aarau cohorts RB Mueller, C Hasler, F Popp, F Mattow, M Durmisi, A Souza, P Hasler, ... Journal of clinical medicine 8 (10), 1548, 2019 | 48 | 2019 |
